MediFind
Condition

Hypogonadotropic Hypogonadism

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Infertility in Men
  • Journal: The Journal of clinical endocrinology and metabolism
  • Treatment Used: Follicle-stimulating hormone Treatment
  • Number of Patients: 0
  • Published —
The study researched the outcomes of follicle-stimulating hormone treatment for men with infertility.
Latest Advance
Study
  • Condition: Effect of Excess Body Fat on Female and Male Reproduction
  • Journal: Metabolism: clinical and experimental
  • Treatment Used: Weight Loss
  • Number of Patients: 0
  • Published —
This review summarizes the evidence on the association of obesity and reproductive health on both the molecular and the clinical level, and the effect of weight-loss interventions on reproductive potential.
Latest Advance
Study
  • Condition: Fertility Issues in Aggressive Pituitary Tumors
  • Journal: Reviews in endocrine & metabolic disorders
  • Treatment Used: Various Treatments
  • Number of Patients: 0
  • Published —
This article discusses the treatment of fertility issues in aggressive pituitary tumors.
Latest Advance
Study
  • Condition: Hypogonadotropic Hypogonadism (HH)
  • Journal: Journal of assisted reproduction and genetics
  • Treatment Used: Gonadotropin
  • Number of Patients: 33
  • Published —
This study evaluated the hormonal profile, antral follicle count (AFC) and ovarian response of patients with hypogonadotropic hypogonadism (HH).
Latest Advance
Study
  • Condition: Testosterone Deficiency (TD)
  • Journal: The journal of sexual medicine
  • Treatment Used: Testosterone Enanthate Auto-Injector
  • Number of Patients: 133
  • Published —
The purpose of this study was to confirm the safety and effectiveness of testosterone enanthate auto-injector in adult men with testosterone deficiency.
Latest Advance
Study
  • Condition: Patients with Benign Prostatic Hyperplasia (BPH) with Hypogonadism
  • Journal: Urologiia (Moscow, Russia : 1999)
  • Treatment Used: Monotherapy with Blockers vs. Combined Therapy
  • Number of Patients: 60
  • Published —
This study compared the efficiency of monotherapy with blockers vs combined therapy (blockers in combination with Androgel) in patients with benign prostatic hyperplasia (enlargement;BPH) and hypogonadism (low testosterone).
Latest Advance
Study
  • Condition: Partial Congenital Hypogonadotropic Hypogonadism (PCHH) or Complete Congenital Hypogonadotropic Hypogonadism (CCHH) in Chinese Patients
  • Journal: Asian journal of andrology
  • Treatment Used: Gonadotropin-Induced Spermatogenesis
  • Number of Patients: 122
  • Published —
This study compared the outcomes of gonadotropin-induced spermatogenesis (hormone-induced sperm production) on patients with partial congenital hypogonadotropic hypogonadism (PCHH) or complete congenital hypogonadotropic hypogonadism (CCHH).
Latest Advance
Study
  • Condition: Men with Previous Myocardial Infarction (MI)
  • Journal: The American journal of cardiology
  • Treatment Used: Testosterone Replacement Therapy (TRT)
  • Number of Patients: 1470
  • Published —
This study determined the incidence of recurrent myocardial infarction (heart attack; MI) and all-cause mortality in subjects with a history of myocardial infarction and low total testosterone (TT) with and without testosterone replacement therapy (TRT).
Latest Advance
Study
  • Condition: Symptomatic Hypogonadism
  • Journal: International braz j urol : official journal of the Brazilian Society of Urology
  • Treatment Used: Human Chorionic Gonadotropin Monotherapy
  • Number of Patients: 20
  • Published —
This study tested the safety and efficacy of using a human chorionic gonadotropin monotherapy to treat men with symptomatic hypogonadism.
Latest Advance
Study
  • Condition: Late-Onset Hypogonadism
  • Journal: American journal of epidemiology
  • Treatment Used: Testosterone Replacement Therapy
  • Number of Patients: 12779
  • Published —
The study researched testosterone replacement therapy and risk of prostate cancer in men with late-onset hypogonadism.